226 related articles for article (PubMed ID: 16230051)
1. Nitroglycerin-patch induced tolerance is associated with reduced ability of nitroglycerin to increase exhaled nitric oxide.
Agvald P; Hammar L; Gustafsson LE
Vascul Pharmacol; 2005 Dec; 43(6):449-57. PubMed ID: 16230051
[TBL] [Abstract][Full Text] [Related]
2. The role of lipoic acid in prevention of nitroglycerin tolerance.
Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
[TBL] [Abstract][Full Text] [Related]
3. Correlation between pulmonary gas exchange and basal and nitroglycerin (GTN)-induced exhaled nitric oxide (eNO) in patients undergoing cardiac surgery.
Kövesi T; Szabo A; Royston D; Marczin N
Vascul Pharmacol; 2005 Dec; 43(6):434-40. PubMed ID: 16278101
[TBL] [Abstract][Full Text] [Related]
4. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
Parker JD; Parker AB; Farrell B; Parker JO
J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
[TBL] [Abstract][Full Text] [Related]
5. Baroreflex resetting but no vascular tolerance in response to transdermal glyceryl trinitrate in conscious rabbits.
Serone AP; Angus JA; Wright CE
Br J Pharmacol; 1996 May; 118(1):93-104. PubMed ID: 8733581
[TBL] [Abstract][Full Text] [Related]
6. Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs.
Nilsson KF; Goździk W; Frostell C; Zieliński S; Zielińska M; Ratajczak K; Skrzypczak P; Rodziewicz S; Albert J; Gustafsson LE
Drug Des Devel Ther; 2018; 12():685-694. PubMed ID: 29636602
[TBL] [Abstract][Full Text] [Related]
7. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.
Shaffer JE; Han BJ; Chern WH; Lee FW
J Pharmacol Exp Ther; 1992 Jan; 260(1):286-93. PubMed ID: 1731043
[TBL] [Abstract][Full Text] [Related]
8. The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits.
Szilvassy Z; Ferdinandy P; Nagy I; Jakab I; Koltai M
Br J Pharmacol; 1997 Jun; 121(3):491-6. PubMed ID: 9179391
[TBL] [Abstract][Full Text] [Related]
9. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
[TBL] [Abstract][Full Text] [Related]
10. In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators.
Smith MP; Humphrey SJ; Kerr SW; Mathews WR
Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):323-35. PubMed ID: 7934311
[TBL] [Abstract][Full Text] [Related]
11. YC-1 enhances the responsiveness of tolerant vascular smooth muscle to glyceryl trinitrate.
O'Reilly DA; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 2001 Jan; 79(1):43-8. PubMed ID: 11201500
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation.
MacPherson JD; Gillespie TD; Dunkerley HA; Maurice DH; Bennett BM
J Pharmacol Exp Ther; 2006 Apr; 317(1):188-95. PubMed ID: 16330494
[TBL] [Abstract][Full Text] [Related]
13. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study.
Gori T; Burstein JM; Ahmed S; Miner SE; Al-Hesayen A; Kelly S; Parker JD
Circulation; 2001 Sep; 104(10):1119-23. PubMed ID: 11535566
[TBL] [Abstract][Full Text] [Related]
14. Direct demonstration of nitric oxide formation in organs of rabbits treated by transdermal glyceryl trinitrate using an in vivo spin trapping technique.
Clermont G; Lecour S; Vergely C; Zeller M; Perrin C; Maupoil V; Bouchot O; Rochette L
Fundam Clin Pharmacol; 2003 Dec; 17(6):709-15. PubMed ID: 15015716
[TBL] [Abstract][Full Text] [Related]
15. Steady-state maternal and fetal plasma concentrations of glyceryl trinitrate (GTN) in the preterm sheep.
Bustard MA; Farley AE; Bennett BM; Smith GN
Can J Physiol Pharmacol; 2003 Sep; 81(9):884-9. PubMed ID: 14614525
[TBL] [Abstract][Full Text] [Related]
16. Detection of nitric oxide in exhaled air during administration of nitroglycerin in vivo.
Persson MG; Agvald P; Gustafsson LE
Br J Pharmacol; 1994 Mar; 111(3):825-8. PubMed ID: 8019758
[TBL] [Abstract][Full Text] [Related]
17. Endothelin ETA receptor antagonist did not affect development of tolerance to glyceryl trinitrate in rat.
Rai A; Bhalla S; Gulati A
J Pharm Pharmacol; 2004 Feb; 56(2):271-5. PubMed ID: 15005887
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of PKC beta by ruboxistaurin does not enhance the acute blood pressure response to nitroglycerin.
Benson C; Seger M; Voelker J
Clin Pharmacol Ther; 2007 Aug; 82(2):181-6. PubMed ID: 17443133
[TBL] [Abstract][Full Text] [Related]
19. [Why does nitroglycerin tolerance appear?].
Włodek L; Sokołowska M
Postepy Hig Med Dosw; 2001; 55(5):673-85. PubMed ID: 11795202
[TBL] [Abstract][Full Text] [Related]
20. Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin.
Abou-Mohamed G; Kaesemeyer WH; Caldwell RB; Caldwell RW
Br J Pharmacol; 2000 May; 130(2):211-8. PubMed ID: 10807657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
